Can antiplatelet therapy after drug eluting stent become a problem?
Many clinical trials demonstrate that demonstrate drug-eluting stents (DES) can improve procedural success in patients with acute coronary syndromes, with a remarkable reduction in the rate of restenosis. On the other hand, it has been shown that stenting can also increase the rate of thrombotic com...
Main Author: | Michele Romano |
---|---|
Format: | Article |
Language: | English |
Published: |
SEEd
2009-03-01
|
Series: | Clinical Management Issues |
Subjects: | |
Online Access: | https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/556 |
Similar Items
-
Optimizing the Duration of Dual Antiplatelet Therapy After Implantation of Drug-eluting Coronary Stents
by: Ying Shen, et al.
Published: (2015-01-01) -
Long-term dual antiplatelet treatment and bleeding complications in diabetic patients treated with drug eluting stent implantation
by: Vassilis Voudris, et al.
Published: (2014-12-01) -
What is the Optimal Duration of Dual Antiplatelet Therapy After Stenting?
by: Udaya S. Tantry, PhD, et al.
Published: (2016-05-01) -
Best duration of dual antiplatelet therapy after drug-eluting stent implantation: an updated network meta-analysis of randomized controlled trials
by: Mahmoud Barbarawi, et al.
Published: (2019-01-01) -
Efficacy and Safety of Very Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stents Implantation for Acute Coronary Syndrome: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
by: Peng-Yu Zhong, et al.
Published: (2021-09-01)